• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911616350
Device Problem Occlusion Within Device (1423)
Patient Problems Chest Pain (1776); Reocclusion (1985)
Event Date 08/10/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported that patient experienced chest pain and in-stent restenosis occurred.In (b)(6) 2012, the patient was referred for cardiac catheterization.Coronary angiography and the index procedure were performed.Target lesion #1 was located in the proximal right coronary artery (rca) with 70% in-stent restenosis (isr) of the previously placed stent and was 5mm long with a reference vessel diameter of 3.5mm.Target lesion #1 was treated with pre-dilatation and placement of a 3.50x12mm promus element¿ plus drug-eluting stent (des).Following post dilatation, residual stenosis was 0% and timi 3 flow noted.Target lesion #2 was located in the mid rca with 70% isr of the previously placed stent and was 5mm long with a reference vessel diameter of 3.5mm.Target lesion #2 was treated with pre dilatation and placement of a 3.50x16mm promus element¿ plus des.Following post dilation, residual stenosis was 0% timi 3 flow noted.A day post-procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2017, the patient presented to the emergency department with the complaint of severe chest pain radiating to left jaw and upper arm and was hospitalized on the same day.The patient was monitored for cardiac enzymes and electrocardiogram (ecg).Since the patient had negative troponin and ecg but had persistent chest pain the patient was referred for catheterization.Four days after, cardiac catheterization was performed.Due to the patient's recent diagnosis of myelodysplastic syndrome it was decided to medically manage his chest pain.Three days after, the patient was discharged home.In (b)(6) 2017, the patient presented with complaints of worsening chest, arm and jaw pain and shortness of breath.The myocardial perfusion imaging test revealed a filling defect in the inferior wall with hypokinesis of the inferior wall.The patent was referred for cardiac catheterization which revealed the rca had 50% proximal stenosis and irregular mid 70-80% in-stent restenosis (isr of study stent).On the same day, based on above mentioned angiography findings a diagnosis of coronary artery disease was confirmed and patient was referred for percutaneous coronary intervention (pci).The isr in the mid rca was treated with a 3.5 x 16mm synergy des with 0% residual stenosis.The next day, the event was considered resolved and the patient was discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7626169
MDR Text Key111916002
Report Number2134265-2018-05581
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 05/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/21/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/01/2013
Device Model NumberH7493911616350
Device Catalogue Number39116-1635
Device Lot Number0015092482
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/30/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/09/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age61 YR
-
-